Peer-reviewedCC BYJournal for ImmunoTherapy of Cancer
1105 HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapy
4 affiliations
- 1NHMRC Clinical Trials Centre, University of Sydney, NSW, Australia
- 2Birmingham Women’s and Children’s NHS Foundation Trust
- 3Case Western Reserve University School of Medicine, Cleveland, OH, USA
- 4Surgery, Case Western Reserve University, Cleveland, Ohio, USA
Related
- ATR inhibition sensitizes pancreatic cancer cells to cytotoxic and immunogenic effects of X-ray and carbon ion irradiation
- HER3 mediates metabolic reprogramming in metastatic colorectal and pancreatic cancer
- Dual inhibition of tumor cells and tumor-associated neutrophils by anti-CXCR2 antibodies suppresses tumor growth and augments immunotherapy efficacy in ARID1A-deficient pancreatic cancer
- Nicotinic acid starvation sensitizes nicotinate phosphoribosyltransferase-expressing tumors to nicotinamide phosphoribosyltransferase inhibition
- Targeting MK2-Driven Stromal Senescence Sensitizes Breast Cancer Bone Metastasis to Immunotherapy
BibTeX
@article{wang20261105,
title = {{1105 HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapy}},
author = {Rui Wang and Elizabeth Bryson and Chao Wei and Kimberly Curry and Moeez Rathore and Jordan Winter},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
month = nov,
doi = {10.1136/jitc-2026-sitc2026.1105},
url = {https://doi.org/10.1136/jitc-2026-sitc2026.1105},
note = {CC BY},
}
RIS
TY - JOUR
TI - 1105 HER3 inhibition sensitizes metastatic colorectal and pancreatic cancer to immunotherapy
AU - Rui Wang
AU - Elizabeth Bryson
AU - Chao Wei
AU - Kimberly Curry
AU - Moeez Rathore
AU - Jordan Winter
PY - 2026
DA - 2026/11/07
JO - Journal for ImmunoTherapy of Cancer
DO - 10.1136/jitc-2026-sitc2026.1105
UR - https://doi.org/10.1136/jitc-2026-sitc2026.1105
SN - 2051-1426
ER -